Metadate ER Interactions
There are 198 drugs known to interact with Metadate ER (methylphenidate), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 20 are major, 167 are moderate, and 11 are minor.
- View all 198 medications that may interact with Metadate ER
- View Metadate ER alcohol/food interactions (4)
- View Metadate ER disease interactions (14)
Most frequently checked interactions
View interaction reports for Metadate ER (methylphenidate) and the medicines listed below.
- Abilify (aripiprazole)
- Ambien (zolpidem)
- bupropion
- buspirone
- clonazepam
- clonidine
- cyclobenzaprine
- Cymbalta (duloxetine)
- fluoxetine
- gabapentin
- ibuprofen
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- lamotrigine
- Lunesta (eszopiclone)
- Lyrica (pregabalin)
- melatonin
- modafinil
- omeprazole
- pantoprazole
- prednisone
- Pristiq (desvenlafaxine)
- propranolol
- Synthroid (levothyroxine)
- Topamax (topiramate)
- trazodone
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Wellbutrin XL (bupropion)
Metadate ER alcohol/food interactions
There are 4 alcohol/food interactions with Metadate ER (methylphenidate).
Metadate ER disease interactions
There are 14 disease interactions with Metadate ER (methylphenidate) which include:
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- substance abuse
- tics
- hypertension
- seizures disorders
- liver disease
- renal dysfunction
- seizure disorders
- hematologic toxicity
- GI narrowing
Report options
QR code containing a link to this page
More about Metadate ER (methylphenidate)
- Metadate ER consumer information
- Compare alternatives
- Reviews (1)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
